These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19540190)

  • 1. Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression.
    Yu Z; Wang H; Zhang L; Tang A; Zhai Q; Wen J; Yao L; Li P
    Biochem Biophys Res Commun; 2009 Sep; 386(4):607-11. PubMed ID: 19540190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoyl bis-hydroxamic acid induces p53-dependent apoptosis of MCF-7 breast cancer cells.
    Zhuang ZG; Fei F; Chen Y; Jin W
    Acta Pharmacol Sin; 2008 Dec; 29(12):1459-66. PubMed ID: 19026165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
    Nakajima W; Tanaka N
    Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis.
    Dogu Y; Díaz J
    Biophys Chem; 2009 Jul; 143(1-2):44-54. PubMed ID: 19395147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
    Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
    Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
    Michod D; Widmann C
    Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells.
    Fischer U; Steffens S; Frank S; Rainov NG; Schulze-Osthoff K; Kramm CM
    Oncogene; 2005 Feb; 24(7):1231-43. PubMed ID: 15592511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
    Chipuk JE; Bouchier-Hayes L; Kuwana T; Newmeyer DD; Green DR
    Science; 2005 Sep; 309(5741):1732-5. PubMed ID: 16151013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integral role of Noxa in p53-mediated apoptotic response.
    Shibue T; Takeda K; Oda E; Tanaka H; Murasawa H; Takaoka A; Morishita Y; Akira S; Taniguchi T; Tanaka N
    Genes Dev; 2003 Sep; 17(18):2233-8. PubMed ID: 12952892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
    Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
    Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways.
    Shibue T; Suzuki S; Okamoto H; Yoshida H; Ohba Y; Takaoka A; Taniguchi T
    EMBO J; 2006 Oct; 25(20):4952-62. PubMed ID: 17024184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway.
    Concannon CG; Koehler BF; Reimertz C; Murphy BM; Bonner C; Thurow N; Ward MW; Villunger A; Strasser A; Kögel D; Prehn JH
    Oncogene; 2007 Mar; 26(12):1681-92. PubMed ID: 16983338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
    Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
    J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis. p53 and PUMA: a deadly duo.
    Vousden KH
    Science; 2005 Sep; 309(5741):1685-6. PubMed ID: 16151000
    [No Abstract]   [Full Text] [Related]  

  • 20. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.